Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Wilkes M et al. - Patients need information about off-label uses to make well-informed health care decisions. The legal doctrine of informed consent should be expanded to require disclosure of off-label prescribing where the drug has not been proven safe and effective for the condition, especially where scientific evidence is inadequate and risks are substantial or unknown. The ethical requirement of SDM should be expanded to require discussions of off-label uses under the same circumstances. Requiring disclosure will protect patient autonomy and educate patients about alternatives and risks, leading to improved health care decisions.

Related Articles

Prescription medication borrowing and sharing - Risk factors and management
Australian Family Physician, 10/05/09    Relevance Score: 46%

Development and Reliability of Items Measuring the Nonmedical Use of Prescription Drugs for the Youth Risk Behavior Survey: Results From an Initial Pilot Test
Journal of School Health, 10/26/09    Relevance Score: 44%

Strong E-Prescribing Growth for Walgreens
HealthDataManagement, 11/13/09    Relevance Score: 43%

Partnership for Prescription Assistance Celebrates Milestone Helping More Than 6 Million Uninsured Patients
PhRMA, 10/23/09    Relevance Score: 43%

Prescription writing for diabetes: compliance with good practice
Nurse Prescribing, 10/12/09    Relevance Score: 43%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address